-
Product Insights
NewInnovations in Magnetic Resonance Imaging (MRI) Contrast Agents – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Magnetic Resonance Imaging (MRI) Contrast Agents - Global Pipeline Summary" provides comprehensive information about the Magnetic Resonance Imaging (MRI) Contrast Agents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Magnetic Resonance Imaging (MRI) Contrast Agents report provides key information and data related to: Extensive coverage of the Magnetic Resonance Imaging (MRI) Contrast Agents under development Review details of major...
-
Sector Analysis
NewMagnetic Resonance Imaging (MRI) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Magnetic Resonance Imaging (MRI) Systems Market Report Overview The MRI systems market size was $5.73 billion in 2023 and will grow at a CAGR of more than 4% during 2023-2033. The increasing prevalence of the aging population and an increase in awareness regarding the importance of early diagnosis of disease which helps in early treatment will fuel the market growth in the coming years. Magnetic Resonance Imaging Systems Market Outlook 2023-2033 ($ Billion) Buy the Full Report for More Insights...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EO-2002 in Corneal Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EO-2002 in Corneal Edema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EO-2002 in Corneal Edema Drug Details: EO-2002 is under development for...
-
Product Insights
NewBio-AMD Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Bio-AMD Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Bio-AMD Inc (Bio-AMD), formerly Flex Fuels Energy Inc, is a medical diagnostic company. The company develops point of care (POC) medical diagnostic device business. It offers bio-alternative medical devices such as digital strip reader for home pregnancy testing applications and blood coagulation monitor, which frequently tests and carefully monitors the prothrombin time (PT), international normalized ratio (INR) and blood coagulation...